Targeted Cancer Therapy

Client:
Endocyte, Inc.

Goal:
Inform investors about the Mechanism of Action (MOA) of Endocyte’s cancer targeting therapies.

Scope:
Depict the MOA process without the use of any three dimensional datasets.

Solution:
Seyet developed a concise and clear portrayal of the MOA to give investors a more tangible feel and understanding of the process this technology utilizes to specifically target diseased cells.